Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition-Reference-Cited by-同舟云学术

Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition

Published:2016-04 Issue:4 Volume:44 Page:924-938
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Salmon Hélène,Idoyaga Juliana,Rahman Adeeb,Leboeuf Marylène,Remark Romain,Jordan Stefan,Casanova-Acebes Maria,Khudoynazarova Makhzuna,Agudo Judith,Tung Navpreet,Chakarov Svetoslav,Rivera Christina,Hogstad Brandon,Bosenberg Marcus,Hashimoto Daigo,Gnjatic Sacha,Bhardwaj Nina,Palucka Anna Karolina,Brown Brian D.,Brody Joshua,Ginhoux Florent,Merad Miriam

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference45 articles.

1. Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival;Bogunovic;Proc. Natl. Acad. Sci. USA,2009

2. TLR4 engagement during TLR3-induced proinflammatory signaling in dendritic cells promotes IL-10-mediated suppression of antitumor immunity;Bogunovic;Cancer Res.,2011

3. Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity;Broz;Cancer Cell,2014

4. Oncology meets immunology: the cancer-immunity cycle;Chen;Immunity,2013

5. Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade;Cooper;Cancer Immunol. Res.,2014

Cited by 915 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flt3 ligand augments immune responses to soluble PD1-based DNA vaccine via expansion of type 1 conventional DCs;International Immunopharmacology;2024-11

2. Deciphering single-cell transcriptomic landscape of tumors in colorectal cancer treated with photothermal semiconducting polymers to design the combination therapy with checkpoint blockades for inhibition of tumor progression and metastasis;Nano Today;2024-10

3. Novel insights into immune cells modulation of tumor resistance;Critical Reviews in Oncology/Hematology;2024-10

4. Secretome and immune cell attraction analysis of head and neck cancers;Cancer Immunology, Immunotherapy;2024-09-09

5. In vivo dendritic cell reprogramming for cancer immunotherapy;Science;2024-09-05